Marilynn Larkin

Non-FDA approved retatrutide is readily available to US consumers from multiple sources, leaving many clinicians grappling with how to manage patients taking the drug.

Canada's new national AI strategy, "AI for All," aims to build trust, expand opportunities, and ensure that AI is used responsibly in healthcare and other industries.

Emerging evidence shows that many people experience food noise, that it can be measured and, at least to some extent, treated with a GLP-1 or other strategy.

A US-based phase 2 trial of an investigational oral GLP-1 called CX11 shows up to 11.5% weight loss and a favorable safety profile among patients living with obesity.

Off-schedule eating disrupts intestinal circadian clocks in mice, offering clues to digestive and metabolic issues in humans.

Off-schedule eating disrupted intestinal circadian clocks in mice, which may help explain digestive and metabolic issues in night-shift workers.

July 10, 2026 Long-term care delays and gaps in home- and community-based care are among the “hidden drivers” of emergency department (ED) overcrowding

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

Sniffing chocolate before sets of leg extensions curbed appetite and increased training volume but not perceived exertion, a pilot study found.

Sunscreen use is heavily promoted on TikTok, but the relatively uncommon posts containing misinformation attract high audience engagement, researchers reported.